PEPTIDE CORTEXThe library
← The library

Tri-Heal

Blend (TB-500 + BPC-157 + KPV)Healing/Recovery
Evidence grade
DResearch/compounded/adjunct (no established FDA indication)
Cardiovascular · 0–5 · separate axis
1
Read first · not dosing instructions

Educational and research reference only. Not medical advice, not a recommendation, and not dosing instructions for any person. Figures are reported from the cited source and may be wrong or out of date. Research peptides are not approved for human use. Adults 18+. Consult a licensed physician before any decision about your health.

PurposeRecovery / inflammation blend (TB-500 + BPC-157 + KPV)
MechanismPre-mixed blend of TB-500, BPC-157 and KPV in one vial (commonly 45 mg). Each component is a separate research compound; the combination itself has not been studied as a product.
EffectsWhat the components are individually studied for: TB-500 — Healing / Recovery; BPC-157 — Healing / Recovery; KPV — Anti-inflammatory / GI. Read each component’s own entry for its evidence.
DosingNo human dose established.
Bottom lineA vendor-defined combination: no trial has tested the blend, and its evidence is no stronger than its weakest component.
Protocols · as published1 sourced
Community protocol — not clinically establishedCommunity guide
RouteSubcutaneous
FrequencyOnce daily
Starting10 units (0.10 mL) once daily at 3 mL reconstitution
Escalation"Advanced" tier: 20 units (0.20 mL) daily
Target10-20 units daily
Cycle4-8 weeks then reassess

Commonly 45 mg = TB-500 25 + BPC-157 10 + KPV 10; some vendors sell an equal 10/10/10 version, so read the composition off the vial. No trial has tested the blend.

Batches on filenone

No tested batches on file.

Read with3
Cautions & interactions

Research-grade blend; not FDA-approved. It carries the cautions of every component — read each one’s entry. Injection-site reactions possible; discuss with a clinician, especially if on anticoagulants or immunosuppressants.

No interaction data for the blend. Each component’s interaction notes apply; avoid combining multiple research compounds without a clinician.

CV 1 of 5 — No cardiovascular outcomes data for the blend; see each component.